Company Profile
Access
Contact Us
Contact Us

Ken Yoshida（Kinki/Osaka）

Department of Radiation Oncology

Associate Professor

We have been enhancing the precision of high-dose-rate (HDR) interstitial brachytherapy. We also provide treatment for sites generally considered difficult to treat, if deemed feasible. In addition to curative treatment, we are also engaged in palliative therapy.

Clinical department/Main areas of expertise
  • Department of Radiation Oncology
    Radiation (Gamma Knife and others)　Detail
    Brachytherapy　Detail
Specialized area
  • Interstitial Brachytherapy for Cancer
    Target diseases: Gynecological cancers, prostate cancer, head and neck cancers, breast cancer, bone and soft tissue tumors, rectal and anal cancer, others.　Detail
surgery
Interstitial Brachytherapy for Cancer
Target diseases: Gynecological cancers, prostate cancer, head and neck cancers, breast cancer, bone and soft tissue tumors, rectal and anal cancer, others.
Qualifications/Academia/Position
  • Board Certified Radiation Oncologist
  • Japanese Society for Radiation Oncology (JASTRO)
  • Japan Radiological Society (JRS)
  • Japan Society for Head and Neck Cancer
  • Japanese Society for Palliative Medicine (JSPM)
  • Delegate, Japanese Society for Radiation Oncology (JASTRO)
  • Secretary, Brachytherapy Committee, Japanese Society for Radiation Oncology (JASTRO)
Affiliated hospital
Kansai Medical University Medical Center
Website
https://hp.kmu.ac.jp/takii/
location
〒570-8507
10-15 Fumizono-cho, City of Moriguchi, Google Map Map
Biography
1994
Graduated from Kobe University School of Medicine
1994
Resident, Department of Radiology, Osaka University Hospital
1995
Trainee, Fifth Department of Internal Medicine, Osaka Prefectural Adult Disease Center
2000
Obtained degree, Graduate School of Medicine (Radiation Oncology), Osaka University
2000
Department of Radiology (currently Department of Radiation Oncology), National Osaka Hospital (now National Hospital Organization Osaka National Hospital)
2011
Concurrently served as Director, Advanced Medical Technology Development Office, EBM Research and Development Department, Clinical Research Center, same hospital
2012
Lecturer, Department of Radiology, Osaka Medical University (Associate Professor since 2020)
2020
Associate Professor, Department of Radiology, Kansai Medical University General Medical Center
paper
  • Combined external radiotherapy and single-fraction palliative high-dose-rate interstitial brachytherapy for a patient with a base of tongue cancer who had a previous radiation history. Oral Radiol. 2025;41:144-150.
  • Single-Fraction Palliative High-Dose-Rate Brachytherapy for Symptom Management in a 97-Year-Old Patient With Dementia. J Palliat Med. 2024;27:1102-6.
  • HDR-brachytherapy for accelerated partial breast irradiation: Long-term experience from a Japanese institution. J Contemp Brachytherapy　2023;15:1-8.
  • Edema worsens target coverage in high-dose-rate interstitial brachytherapy of mobile tongue cancer: a report of two cases. J Contemp Brachytherapy 2017;9:66-70.
  • Simulation analysis of optimized brachytherapy for uterine cervical cancer: Can we select the best brachytherapy modality depending on tumor size? Brachytherapy. 2016;15:57-64
  • Role of vaginal pallor reaction in predicting late vaginal stenosis after high-dose-rate brachytherapy in treatment-naive patients with cervical cancer. J Gynecol Oncol. 2015;26:179-84.
  • "Treatment results of image-guided high-dose-rate interstitial brachytherapy for pelvic recurrence of uterine cancer. " Brachytherapy. 2015;14:440-8.
  • "Preliminary results of MRI-assisted high-dose-rate interstitial brachytherapy for uterine cervical cancer. " Brachytherapy. 2015;14:1-8.
  • Longitudinal analysis of late vaginal mucosal reactions after high-dose-rate brachytherapy in patients with gynecological cancer. Anticancer Res 2014;34:4433-8.
  • Role of novel risk classification method, Prostate Cancer Risk Index (PRIX) for clinically localized prostate cancer after high-dose-rate interstitial brachytherapy as monotherapy. Anticancer Res 2014;34:3077-81.

This doctor's treatment program

  • Brachytherapy [Kansai Medical University General Medical Center]

    Kansai Medical University Hospital（Kinki/Osaka）

    Advancement of high-precision high-dose-rate interstitial brachytherapy Not only curative treatment but also palliative care

    We have been advancing the precision of high-dose-rate (HDR) interstitial brachytherapy. We use the third-generation remote afterloading system, MicroSelectron-HDR. In addition to curative treatment, we are also engaged in palliative therapy.

    See details
Back to search results list Return to "facilities"